Jatinder S. Minhas

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Yining Huang, Richard I. Lindley, Xiaoying Chen et al. · The Lancet · 2019 · 271 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study

Christopher Martin, David R. Jenkins, Jatinder S. Minhas et al. · EClinicalMedicine · 2020 · 175 citations · Full text

Public Health, Infectious Disease Control, Population Health Sciences +15

The need for improved discharge criteria for hospitalised patients with COVID-19—implications for patients in long-term care facilities

Shirley Sze, Daniel Pan, Caroline Williams et al. · Age and Ageing · 2020 · 73 citations · Full text

Medicine, Infectious Diseases, Continuity Of Care +16

Acid–base balance and cerebrovascular regulation

Hannah G. Caldwell, Jay M. J. R. Carr, Jatinder S. Minhas et al. · The Journal of Physiology · 2021 · 51 citations

Life Sciences, Physiology, Cellular Metabolism +16